PMID: 9150159

Macek M Jr, Mackova A, Hamosh A, Hilman BC, Selden RF, Lucotte G, Friedman KJ, Knowles MR, Rosenstein BJ, Cutting GR
Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%.
Am J Hum Genet. 1997 May;60(5):1122-7., [PubMed]
Sentences
No. Mutations Sentence Comment
39 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 9150159:39:176
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9150159:39:208
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9150159:39:284
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 9150159:39:255
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 9150159:39:194
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 9150159:39:201
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9150159:39:296
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9150159:39:234
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 9150159:39:241
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 9150159:39:262
status: NEW
view ABCC7 p.Arg560Thr details
Mutation Analysis All patients were screened for the AF508 mutation and 15 common Caucasian CF mutations using a reverse dot strip hybridization system (Kawasaki et al. 1993) (R117H, 621+1G--T, R334W, R347P, A455E, A1507, 1717-1G-+A, G542X, S549N, GSS1D, R553X, R560T, 3849+10kbC-+T, W1282X, and N1303K) (Welsh et al. 1995) and a deep intron 11 splice-site mutation, 1811+1.6kbA-+G (Chillon et al. 1995). Login to comment
40 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 9150159:40:176
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9150159:40:208
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9150159:40:284
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 9150159:40:255
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 9150159:40:194
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 9150159:40:201
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9150159:40:296
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9150159:40:234
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 9150159:40:241
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 9150159:40:262
status: NEW
view ABCC7 p.Arg560Thr details
Mutation Analysis All patients were screened for the AF508 mutation and 15 common Caucasian CF mutations using a reverse dot strip hybridization system (Kawasaki et al. 1993) (R117H, 621+1G--T, R334W, R347P, A455E, A1507, 1717-1G-+A, G542X, S549N, GSS1D, R553X, R560T, 3849+10kbC-+T, W1282X, and N1303K) (Welsh et al. 1995) and a deep intron 11 splice-site mutation, 1811+1.6kbA-+G (Chillon et al. 1995). Login to comment
45 ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 9150159:45:253
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Ser1255*
X
ABCC7 p.Ser1255* 9150159:45:374
status: NEW
view ABCC7 p.Ser1255* details
ABCC7 p.Gly480Cys
X
ABCC7 p.Gly480Cys 9150159:45:227
status: NEW
view ABCC7 p.Gly480Cys details
ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 9150159:45:283
status: NEW
view ABCC7 p.Ala559Thr details
In the two independent African-American groups, samples were screened for eight mutations that have been identified in two or more African-American CF patients, including 405+3A-+C (present study), 444delA (White et al. 1991), G480C (Smit et al. 1995), R553X (Cutting et al. 1990b), A559T (Cutting et al. 1990b), 2307insA (Smit et al. 1993), 3120+1G-+A (present study), and S1255X (Cutting et al. Login to comment
46 ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 9150159:46:253
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Ser1255*
X
ABCC7 p.Ser1255* 9150159:46:374
status: NEW
view ABCC7 p.Ser1255* details
ABCC7 p.Gly480Cys
X
ABCC7 p.Gly480Cys 9150159:46:227
status: NEW
view ABCC7 p.Gly480Cys details
ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 9150159:46:283
status: NEW
view ABCC7 p.Ala559Thr details
In the two independent African-American groups, samples were screened for eight mutations that have been identified in two or more African-American CF patients, including 405+3A-+C (present study), 444delA (White et al. 1991), G480C (Smit et al. 1995), R553X (Cutting et al. 1990b), A559T (Cutting et al. 1990b), 2307insA (Smit et al. 1993), 3120+1G-+A (present study), and S1255X (Cutting et al. Login to comment
47 ABCC7 p.Ser1255*
X
ABCC7 p.Ser1255* 9150159:47:64
status: NEW
view ABCC7 p.Ser1255* details
ABCC7 p.Gly480Cys
X
ABCC7 p.Gly480Cys 9150159:47:43
status: NEW
view ABCC7 p.Gly480Cys details
Screening protocols for mutations 444delA, G480C, 2307insA, and S1255X were previously reported in the references cited in the preceding sentence. Login to comment
48 ABCC7 p.Ser1255*
X
ABCC7 p.Ser1255* 9150159:48:64
status: NEW
view ABCC7 p.Ser1255* details
ABCC7 p.Gly480Cys
X
ABCC7 p.Gly480Cys 9150159:48:43
status: NEW
view ABCC7 p.Gly480Cys details
ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 9150159:48:4
status: NEW
view ABCC7 p.Ala559Thr details
The A559T mutation creates a unique MseI restriction site. Login to comment
49 ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 9150159:49:4
status: NEW
view ABCC7 p.Ala559Thr details
The A559T mutation creates a unique MseI restriction site. Login to comment
61 ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 9150159:61:85
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Ser1255*
X
ABCC7 p.Ser1255* 9150159:61:111
status: NEW
view ABCC7 p.Ser1255* details
ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 9150159:61:96
status: NEW
view ABCC7 p.Ala559Thr details
Four other mutations were observed more than once in the index group (405+3A--C [2], R553X [3], A559T [2], and S1255X [2]). Login to comment
62 ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 9150159:62:85
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Ser1255*
X
ABCC7 p.Ser1255* 9150159:62:111
status: NEW
view ABCC7 p.Ser1255* details
ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 9150159:62:96
status: NEW
view ABCC7 p.Ala559Thr details
ABCC7 p.Trp19Cys
X
ABCC7 p.Trp19Cys 9150159:62:60
status: NEW
view ABCC7 p.Trp19Cys details
Twelve novel mutations were identified in one patient each: W19C, 621G--*A, 1002-3T-*G, Am. J. Hum. Genet. Login to comment
63 ABCC7 p.Arg764*
X
ABCC7 p.Arg764* 9150159:63:819
status: NEW
view ABCC7 p.Arg764* details
ABCC7 p.Tyr563Asp
X
ABCC7 p.Tyr563Asp 9150159:63:676
status: NEW
view ABCC7 p.Tyr563Asp details
ABCC7 p.Ser364Pro
X
ABCC7 p.Ser364Pro 9150159:63:549
status: NEW
view ABCC7 p.Ser364Pro details
ABCC7 p.Gly330*
X
ABCC7 p.Gly330* 9150159:63:482
status: NEW
view ABCC7 p.Gly330* details
ABCC7 p.Trp19Cys
X
ABCC7 p.Trp19Cys 9150159:63:60
status: NEW
view ABCC7 p.Trp19Cys details
ABCC7 p.Trp19Cys
X
ABCC7 p.Trp19Cys 9150159:63:185
status: NEW
view ABCC7 p.Trp19Cys details
60:1122-1127, 1997 Table 1 Novel CFTR Mutations Identified in This Study, in African-American CF Patients Mutation Nucleotide Change Exon/Intron Consequence Location Screening Method 1 W19C G-OT at 189 Exon 2 Trp-Cys at 19 ... Loss of AvaII; ASO 2 405+3A-C A-C at 405+3 Intron 3 Splice mutation TM 1 ASO 3 621G-A G-IA at 621 Exon 4 Splice mutation ... ASO 4 1002-3T-G T-G at 1002-3 Intron 6B Splice mutation ... ASO 5 1119delA delA at 1119 Exon 7 Frameshift ... Direct sequencing 6 G330X G-OT at 1120 Exon 7 Gly-+Stop at 330 ... Direct sequencing 7 S364P T-C at 1222 Exon 7 Ser-Pro at 364 ... Loss of Hinfl; ASO 8 1504delG deIG at 1504 Exon 9 Frameshift NBF I Loss of BamHI 9 Y563D T-OG at 1819 Exon 12 Tyr-Asp at 563 NBF I Loss of XcaI; ASO 10 1618T T-IC at 1985 Exon 13 Ile-'Thr at 618 R Loss of VspI or AsuI; ASO 11 R764X C-T at 2422 Exon 13 Arg-Stop at 764 R Direct sequencing 12 2734delG/insAT delG/insAT at 2734 Exon 14A Frameshift TM 7 Creates VspI or Pad 13 3120+1G-A GI-A at 3120+1 Intron 16 Splice mutation TM 9 Loss of BstNI 14 3791delC delC at 3791 Exon 19 Frameshift ... Direct sequencing NoTE. Login to comment
64 ABCC7 p.Arg764*
X
ABCC7 p.Arg764* 9150159:64:819
status: NEW
view ABCC7 p.Arg764* details
ABCC7 p.Tyr563Asp
X
ABCC7 p.Tyr563Asp 9150159:64:676
status: NEW
view ABCC7 p.Tyr563Asp details
ABCC7 p.Ser364Pro
X
ABCC7 p.Ser364Pro 9150159:64:549
status: NEW
view ABCC7 p.Ser364Pro details
ABCC7 p.Gly330*
X
ABCC7 p.Gly330* 9150159:64:482
status: NEW
view ABCC7 p.Gly330* details
ABCC7 p.Trp19Cys
X
ABCC7 p.Trp19Cys 9150159:64:185
status: NEW
view ABCC7 p.Trp19Cys details
60:1122-1127, 1997 Table 1 Novel CFTR Mutations Identified in This Study, in African-American CF Patients Mutation Nucleotide Change Exon/Intron Consequence Location Screening Method 1 W19C G-OT at 189 Exon 2 Trp-Cys at 19 ... Loss of AvaII; ASO 2 405+3A-C A-C at 405+3 Intron 3 Splice mutation TM 1 ASO 3 621G-A G-IA at 621 Exon 4 Splice mutation ... ASO 4 1002-3T-G T-G at 1002-3 Intron 6B Splice mutation ... ASO 5 1119delA delA at 1119 Exon 7 Frameshift ... Direct sequencing 6 G330X G-OT at 1120 Exon 7 Gly-+Stop at 330 ... Direct sequencing 7 S364P T-C at 1222 Exon 7 Ser-Pro at 364 ... Loss of Hinfl; ASO 8 1504delG deIG at 1504 Exon 9 Frameshift NBF I Loss of BamHI 9 Y563D T-OG at 1819 Exon 12 Tyr-Asp at 563 NBF I Loss of XcaI; ASO 10 1618T T-IC at 1985 Exon 13 Ile-'Thr at 618 R Loss of VspI or AsuI; ASO 11 R764X C-T at 2422 Exon 13 Arg-Stop at 764 R Direct sequencing 12 2734delG/insAT delG/insAT at 2734 Exon 14A Frameshift TM 7 Creates VspI or Pad 13 3120+1G-A GI-A at 3120+1 Intron 16 Splice mutation TM 9 Loss of BstNI 14 3791delC delC at 3791 Exon 19 Frameshift ... Direct sequencing NoTE. Login to comment
65 ABCC7 p.Tyr563Asp
X
ABCC7 p.Tyr563Asp 9150159:65:429
status: NEW
view ABCC7 p.Tyr563Asp details
ABCC7 p.Ser364Pro
X
ABCC7 p.Ser364Pro 9150159:65:382
status: NEW
view ABCC7 p.Ser364Pro details
ABCC7 p.Ile618Thr
X
ABCC7 p.Ile618Thr 9150159:65:487
status: NEW
view ABCC7 p.Ile618Thr details
ABCC7 p.Trp19Cys
X
ABCC7 p.Trp19Cys 9150159:65:138
status: NEW
view ABCC7 p.Trp19Cys details
Oligonucleotides for allele-specific oligonucleotide (ASO) hybridization screening of novel African-American CF mutations are as follows: W19C, 5'-FI-TI TAG CTG TAC CAG ACC A-3' (final wash [FW] at 510C); 405+3 A-C, 5'-ATT TAG GGG TCA GGA TCT-3' (FW at 530C); 621 G-IA, 5'-TTG ATT TAT AAG AAA GTA ATA CTT-3' (FW at 54'C); 1002-3 T-G, 5'-GTT CTG TTC TAT AAA AAA CAA-3' (FW at 53'C); S364P, 5'-GTA TGA CCC TCT TGG-3' (FW at 450C); Y563D, 5'-TCA TCT TTG TCT ACT GAG AG-3' (FW at 510C); and I618T, 5'-CAA AAT ATFT AAC TlT- GCA TGA A-3' (FW at 520C). Login to comment
66 ABCC7 p.Arg764*
X
ABCC7 p.Arg764* 9150159:66:48
status: NEW
view ABCC7 p.Arg764* details
ABCC7 p.Tyr563Asp
X
ABCC7 p.Tyr563Asp 9150159:66:34
status: NEW
view ABCC7 p.Tyr563Asp details
ABCC7 p.Tyr563Asp
X
ABCC7 p.Tyr563Asp 9150159:66:428
status: NEW
view ABCC7 p.Tyr563Asp details
ABCC7 p.Ser364Pro
X
ABCC7 p.Ser364Pro 9150159:66:17
status: NEW
view ABCC7 p.Ser364Pro details
ABCC7 p.Ser364Pro
X
ABCC7 p.Ser364Pro 9150159:66:381
status: NEW
view ABCC7 p.Ser364Pro details
ABCC7 p.Gly330*
X
ABCC7 p.Gly330* 9150159:66:10
status: NEW
view ABCC7 p.Gly330* details
ABCC7 p.Ile618Thr
X
ABCC7 p.Ile618Thr 9150159:66:486
status: NEW
view ABCC7 p.Ile618Thr details
ABCC7 p.Trp19Cys
X
ABCC7 p.Trp19Cys 9150159:66:138
status: NEW
view ABCC7 p.Trp19Cys details
1119delA, G330X, S364P, 1504delG, Y563D, 1618T, R764X, 2734delG/insAT, and 3791delC (table 1). Login to comment
67 ABCC7 p.Arg764*
X
ABCC7 p.Arg764* 9150159:67:48
status: NEW
view ABCC7 p.Arg764* details
ABCC7 p.Tyr563Asp
X
ABCC7 p.Tyr563Asp 9150159:67:34
status: NEW
view ABCC7 p.Tyr563Asp details
ABCC7 p.Ser364Pro
X
ABCC7 p.Ser364Pro 9150159:67:17
status: NEW
view ABCC7 p.Ser364Pro details
ABCC7 p.Gly330*
X
ABCC7 p.Gly330* 9150159:67:10
status: NEW
view ABCC7 p.Gly330* details
ABCC7 p.Trp19Cys
X
ABCC7 p.Trp19Cys 9150159:67:15
status: NEW
view ABCC7 p.Trp19Cys details
Of these, only W19C occurred in a pancreatic-sufficient patient. Login to comment
68 ABCC7 p.Trp19Cys
X
ABCC7 p.Trp19Cys 9150159:68:15
status: NEW
view ABCC7 p.Trp19Cys details
Of these, only W19C occurred in a pancreatic-sufficient patient. Login to comment
70 ABCC7 p.Trp1316*
X
ABCC7 p.Trp1316* 9150159:70:319
status: NEW
view ABCC7 p.Trp1316* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9150159:70:132
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg352Gln
X
ABCC7 p.Arg352Gln 9150159:70:106
status: NEW
view ABCC7 p.Arg352Gln details
ABCC7 p.Val520Phe
X
ABCC7 p.Val520Phe 9150159:70:113
status: NEW
view ABCC7 p.Val520Phe details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 9150159:70:139
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Gly480Cys
X
ABCC7 p.Gly480Cys 9150159:70:238
status: NEW
view ABCC7 p.Gly480Cys details
ABCC7 p.Gln98Arg
X
ABCC7 p.Gln98Arg 9150159:70:100
status: NEW
view ABCC7 p.Gln98Arg details
ABCC7 p.Tyr913Cys
X
ABCC7 p.Tyr913Cys 9150159:70:150
status: NEW
view ABCC7 p.Tyr913Cys details
Finally, 13 mutations found in one patient each had been previously reported in Caucasian patients (Q98R, R352Q, V520F, 1812-1G--A, G542X, S549N, and Y913C) (Romey et al. 1995; Welsh et al. 1995) or in African-American patients (444delA, G480C, 1342-2delAG [originally reported as 1342-1G--+C], 2307insA, 3662delA, and W1316X) (Cutting et al. 1990b; White et al. 1991; Zielenski et al. Login to comment
71 ABCC7 p.Trp1316*
X
ABCC7 p.Trp1316* 9150159:71:319
status: NEW
view ABCC7 p.Trp1316* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9150159:71:132
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg352Gln
X
ABCC7 p.Arg352Gln 9150159:71:106
status: NEW
view ABCC7 p.Arg352Gln details
ABCC7 p.Val520Phe
X
ABCC7 p.Val520Phe 9150159:71:113
status: NEW
view ABCC7 p.Val520Phe details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 9150159:71:139
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Gly480Cys
X
ABCC7 p.Gly480Cys 9150159:71:238
status: NEW
view ABCC7 p.Gly480Cys details
ABCC7 p.Gln98Arg
X
ABCC7 p.Gln98Arg 9150159:71:100
status: NEW
view ABCC7 p.Gln98Arg details
ABCC7 p.Tyr913Cys
X
ABCC7 p.Tyr913Cys 9150159:71:150
status: NEW
view ABCC7 p.Tyr913Cys details
Finally, 13 mutations found in one patient each had been previously reported in Caucasian patients (Q98R, R352Q, V520F, 1812-1G--A, G542X, S549N, and Y913C) (Romey et al. 1995; Welsh et al. 1995) or in African-American patients (444delA, G480C, 1342-2delAG [originally reported as 1342-1G--+C], 2307insA, 3662delA, and W1316X) (Cutting et al. 1990b; White et al. 1991; Zielenski et al. Login to comment
86 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 9150159:86:224
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9150159:86:293
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9150159:86:472
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 9150159:86:402
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 9150159:86:629
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 9150159:86:261
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 9150159:86:277
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9150159:86:491
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9150159:86:348
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 9150159:86:367
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 9150159:86:432
status: NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Ser1255*
X
ABCC7 p.Ser1255* 9150159:86:731
status: NEW
view ABCC7 p.Ser1255* details
ABCC7 p.Gly480Cys
X
ABCC7 p.Gly480Cys 9150159:86:609
status: NEW
view ABCC7 p.Gly480Cys details
ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 9150159:86:660
status: NEW
view ABCC7 p.Ala559Thr details
The most common muta- Table 2 Distribution of CF Mutations in African-American and U.S.-Caucasian CF Patients African-American U.S. Caucasiana Mutation (n= 148) % (n = 8,714) % Caucasian mutations: AF508 71 48 5,769 66.2 R117H 0 0 47 .5 621+1 G--T 0 0 68 .8 R334W 1 .7 7 .1 R347P 0 0 24 .3 A455E 0 0 5 .1 AI507 1 .7 10 .1 1717-1 G-IA 1 .7 39 .5 G542X 1 .7 204 2.3 S549N 1 .7 4 .1 GS51D 1 .7 173 2.0 R553X (Caucasian)b 0 0 87 1.0 R560T 0 0 16 .2 3849+10kb C-T 0 0 51 .6 W1282X 0 0 235 2.7 N1303K 0 0 116 1.3 Subtotal 77 52 6,855 78.7 African-American mutations: 405+3 A-C 2 1.4 ... ... 444delA 1 .7 ... ... G480C 2 1.4 ... ... R553X (African)b 3 2.0 ... ... A559T 3 2.0 ... ... 2307insA 3 2.0 ... ... 3120+1 GC-A 18 12.2 ... ... S1255X 2 1.4 ... ... Subtotal 34 23 ... ... Total 111 75.0 6,855 78.7 NOTE.-Percentages are rounded. Login to comment
87 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 9150159:87:224
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9150159:87:293
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9150159:87:472
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 9150159:87:402
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 9150159:87:629
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 9150159:87:261
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 9150159:87:277
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9150159:87:491
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9150159:87:348
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 9150159:87:367
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 9150159:87:432
status: NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Ser1255*
X
ABCC7 p.Ser1255* 9150159:87:731
status: NEW
view ABCC7 p.Ser1255* details
ABCC7 p.Gly480Cys
X
ABCC7 p.Gly480Cys 9150159:87:609
status: NEW
view ABCC7 p.Gly480Cys details
ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 9150159:87:660
status: NEW
view ABCC7 p.Ala559Thr details
The most common muta- Table 2 Distribution of CF Mutations in African-American and U.S.-Caucasian CF Patients African-American U.S. Caucasiana Mutation (n= 148) % (n = 8,714) % Caucasian mutations: AF508 71 48 5,769 66.2 R117H 0 0 47 .5 621+1 G--T 0 0 68 .8 R334W 1 .7 7 .1 R347P 0 0 24 .3 A455E 0 0 5 .1 AI507 1 .7 10 .1 1717-1 G-IA 1 .7 39 .5 G542X 1 .7 204 2.3 S549N 1 .7 4 .1 GS51D 1 .7 173 2.0 R553X (Caucasian)b 0 0 87 1.0 R560T 0 0 16 .2 3849+10kb C-T 0 0 51 .6 W1282X 0 0 235 2.7 N1303K 0 0 116 1.3 Subtotal 77 52 6,855 78.7 African-American mutations: 405+3 A-C 2 1.4 ... ... 444delA 1 .7 ... ... G480C 2 1.4 ... ... R553X (African)b 3 2.0 ... ... A559T 3 2.0 ... ... 2307insA 3 2.0 ... ... 3120+1 GC-A 18 12.2 ... ... S1255X 2 1.4 ... ... Subtotal 34 23 ... ... Total 111 75.0 6,855 78.7 NOTE.-Percentages are rounded. Login to comment
89 ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 9150159:89:5
status: NEW
view ABCC7 p.Arg553* details
bThe R553X mutation was included in each group of common mutations, since it has arisen independently in the Caucasian and African populations on different chromosome backgrounds (Reiss et al. 1991). Login to comment
90 ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 9150159:90:5
status: NEW
view ABCC7 p.Arg553* details
bThe R553X mutation was included in each group of common mutations, since it has arisen independently in the Caucasian and African populations on different chromosome backgrounds (Reiss et al. 1991). Login to comment